Skip to content

Personalized Therapy Study - HFRS (TriageHF) Post Approval Study

Personalized Therapy Study - Heart Failure Risk Status (TriageHF) Post Approval Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04489225
Enrollment
2200
Registered
2020-07-28
Start date
2020-08-01
Completion date
2028-01-31
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Brief summary

Medtronic is sponsoring the HFRS PAS to evaluate the HFRS feature (TriageHF) when used in routine clinical practice following commercial release. The HFRS PAS is conducted within Medtronic's Product Surveillance Registry (PSR) platform.

Detailed description

The HFRS PAS is a global, prospective, observational, multi-site study. Patients implanted with a Medtronic Cobalt™ XT CRT (with Attain StabilityQuad™ MRI SureScan™ Model 4798 Lead (ASQ)) or ICD device who are enrolled in the Medtronic CareLink (CL) Network and the PSR will be followed per the standard of care practices of their care provider.

Interventions

OTHERObservational

Observational only without any intervention

Sponsors

Medtronic
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements * Patient has or is intended to receive or be treated with an eligible ICD or CRT device or Patients may be enrolled pre-implant and up to 30 days post-implant following confirmation of patient eligibility. * Patient is enrolled in the Medtronic CareLink® Network for remote monitoring.

Exclusion criteria

* Patient who is, or is expected to be inaccessible for follow-up * Patient with

Design outcomes

Primary

MeasureTime frameDescription
positive predictive value (PPV) of HFRS High Risk Status associated with worsening heart failureUp to 5 yearsTo estimate the positive predictive value (PPV) of HFRS High Risk Status associated with worsening heart failure

Secondary

MeasureTime frameDescription
Number of HF hospitalization or HF related deathsUp to 5 yearsSummarize the number of HF hospitalization or HF related deaths that were not preceded by a High-Risk Status.

Countries

France, Greece, Italy, Portugal, Slovakia, Spain, Switzerland, United Kingdom, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026